Bictegravir
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
magaldrate
Nonsystemic antacid · Antacid
Nonsystemic antacidAntacid
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
7 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 7 →
- BictegravirSevereDatabaseDDInter
- DolutegravirSevereDatabaseDDInter
- ErdafitinibSevereDatabaseDDInter
- PatiromerSevereDatabaseDDInter
Mechanism
Magaldrate is a hydrated complex of hydroxymagnesium aluminate that rapidly reacts with acid to release aluminum hydroxide. The freshly released aluminum hydroxide then reacts more slowly, providing prompt and sustained neutralizing action.
Indications
Antacid
Drug interactions
Dolutegravir
Severe
Database
Clinical effect not specified
Source: DDInter
Erdafitinib
Severe
Database
Clinical effect not specified
Source: DDInter
Patiromer
Severe
Database
Clinical effect not specified
Source: DDInter
Raltegravir
Severe
Database
Clinical effect not specified
Source: DDInter
Selpercatinib
Severe
Database
Clinical effect not specified
Source: DDInter
Tolevamer
Severe
Database
Clinical effect not specified
Source: DDInter
5 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Other Nonsystemic antacid drugs
Ask House about magaldrate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team